Image Courtesy of Catholic University
By Caroline Morris
Catholic Universitys Student Government Association (SGA) held a virtual town hall on October 26 from 7-8 p.m. with University President John Garvey to answer questions about the future of the Class of 2022.
Student Government Association President Gerald Sharpe and Garvey hosted the town hall via Zoom with contributions from Vice President for Student Affairs Judi Briggs Garbuio, Director of Campus Activities Steve Kreider, and Vice Provost for Teaching and Dean of Undergraduate Studies Lynn Mayer.
SGA sent an email to the junior class the week prior to the town hall with a Google Form on which students could submit questions for Garvey. The Zoom webcast also allowed for live question submission and a raise hand button for students to speak directly to the hosts. The questions focused primarily on the future of the junior class, including whether they would be allowed back on campus in the spring, housing logistics, and the possibility of in-person classes. The following paragraphs detail questions posed by students and the panels answers.
Why were freshmen chosen to go back this Fall?
Juniors have been upset with the choice to allow freshmen on campus when upperclassmen have more specialized courses that require on campus resources more. Garvey maintained his position on the choice to allow only freshmen on campus.
We were afraid [the freshmen] would just never get attached to the institution unless we can bring them in and give them a full sort of experience, Garvey said. While administration does not regret this decision, they are also cognizant of the fact that this choice did come at the detriment of upperclassmen. He commented I hate it about the problem this has caused for upperclassmen and expressed how anxious CUA is to open in the spring.
How well is the University handling COVID-19 cases?
There are about 600 residential students living at Catholic now, as well as many students off campus. Garvey did acknowledge the spikes of cases they had early on, but maintained a positive attitude toward the universitys COVID-19 safety procedures, including statistics that only 40% of cases have been on campus and that there is only one positive case on campus at the moment.
Were more open than any other university in the city, and weve learned a lot, Garvey said. I think weve got to a point now where its pretty safe on campus.
Will the juniors be able to return to campus in the spring? What does this mean for classes, housing, and facility usage?
The big topic on everyones mind was about the likelihood of juniors being able to return to campus next semester and what that means for the living situation, in-person classes, and facility usage. Garvey was very clear in his intention to allow those in need of university facilities, such as architecture students or those in the music school, onto campus for building use. In regards to the question about juniors being allowed to live on campus and take in-person classes, Garvey was quite positive:
The answer to both is yes, I think.
He did distinguish that there were two variables when referring to reopening. One is that of in-person classes, and the other is housing.
We would like to be as open as our capacity permits, Garvey said in regards to in-person classes. He also acknowledged that there were a few variables they needed to consider, including having faculty who feel safe and willing to teach in person, space for classroom availability given distancing measures, and the timing of schedules given the necessity of cleaning procedures after each class.
Garvey was unable to give a definitive timeline for when students will know about in-person classes, as collecting the data to determine which classes can meet in person takes longer than you might suppose, Garvey said.
The other aspect of reopening is housing. Students recently were allowed to fill out a housing application for the spring semester and 578 students requested to be considered for on-campus housing, of which 140 were juniors. According to Garbuio, there are a few more applicants than beds available, but they are trying to accommodate.
Garbuio said that juniors will be moved into traditional residence halls, which include Regan, Ryan, Flather, Caldwell, Seton, and Gibbons. This poses a problem for juniors, as they have already spent their freshman year in many of these dorms and because these dorms do not have suites. This means that upperclassmen, who are typically not forced to have meal plans, will have to share a communal kitchen with a large residence hall. This is a significant shock to juniors, as seen in the question posed by Steve Kreider on behalf of students submitting comments through the Q&A function, addressing the negative effects of this housing decision for upperclassmen who have already paid their dues in communal residence halls and meals plans.
There was an explanation of this decision to place juniors in freshman dorms and keep freshmen in upperclassman dorms.
It would be really difficult for [first years who have already settled on campus] to be then redistributed throughout the campus community and other environments, said Garbuio.
The hopeful deadline for releasing housing assignments is December 7th.
Will students be able to defer on-campus residence and finish the semester at home in the event of a switch to online classes or by choice?
Garbuio confirmed that Catholic U will be very clear in [their] communication for those of you that are interested in on-campus housing about what the deadline would be to accept or not commit to the housing for the spring semester. It was also confirmed that students may decide to finish this year entirely online.
How can we trust the universitys word? What is the contingency plan for the spring?
An anonymous student addressed the fact that the university committed to opening for the fall semester and then blindsided us last minute with a switch to online. Garvey addressed this as a matter of hope and adherence. The university waited so long to change the plan because it was committed and hopeful to staying open, but with a spike of COVID cases in D.C., they had to adhere to an order that would not allow them to bring everyone back to campus. This same issue persists to the plans for the spring. The university remains committed to bringing students back, but the progression of the virus, the legal environment, and the decisions of the city will affect the universitys ability to do so.
Garvey did feel confident that if students are allowed back on campus, it will not result in a similar situation to the spring 2020 semester where all students were sent home. One of the benefits of having freshmen on campus is that it has given [the university] some practice in how to deal with COVID spikes. Rather than send students home when cases spike, they run the cases through the inventory of classes, and if certain classes reach a predetermined percentage of infections, those classes will move online for a quarantine period.
There is a change to the spring semester calendar.
Classes will begin on January 25 and the University will cancel spring break, also minimizing Easter break to reduce COVID cases brought to the university through travel.
Study Abroad, Sports, Mental Health, and COVID-Vaccines
The Town Hall also touched on a few other topics briefly. Mayer discussed that because Study Abroad programs have been stopped for the spring, their focus is on summer programs. Garvey expressed his interest in allowing sports teams to play in the Landmark Conference, but that is yet to be confirmed. He also expressed pride in the mental health assistance the university is offering through the counseling center. When asked if the university will require students to get a COVID vaccine if it were created using aborted fetal stem cells, Garvey reiterated his thoughts given during the last town hall on COVID vaccines using aborted fetal stem cells, saying, No, I dont think we will.
Faculty pay cuts
The concerns of students about faculty pay cuts were addressed, and Garvey revealed that the university has lost 46 million dollars as a result of the pandemic. Cuts have had to be made, but there have been as many efforts as possible to keep jobs and a liveable salary for all.
Final Words
Throughout the town hall, Garvey maintained that the university was committed to having students back on campus in the spring. Though the virus may change and the future of the city cannot be predicted, Garvey sustained his positivity: Im hopeful.
Read the rest here:
SGA Class of 2022 Town Hall - Catholic University of America The Tower
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments